Academic Year |
Graduated Student |
Thesis title |
2023 |
Giulia Pagliari |
A new antidiabetic agent showing PPARα/γ dual agonism and mitochondrial pyruvate carrier inhibition
|
2023 |
Sergio Scarpa |
Identification of novel inhibitors of Superoxide Dismutase from Streptococcus mutans by virtual screening studies
|
2022 |
Rosa Marchese |
Identification of a novel PPAR pan-agonist for the treatment of the metabolic syndrome by chemoinformatic methods
|
2021 |
Giulia Manfellotti |
Identification of novel 5-Lipoxygenase-Activating Protein (FLAP) inhibitors by advanced computational techniques
|
2020 |
Valeria Patarino |
Identification of sulfonimide and amide derivatives as novel PPARα antagonists with antiproliferative activity on paraganglioma cell lines
|
2020 |
Debora Iorio |
Novel phenyldiazenyl fibrate analogues as PPARα/β/γ pan-agonists for the amelioration of metabolic syndrome
|
2020 |
Antonio Lombardi |
Two decades pf successful SAR-grounded stories of the novel bacterial topoisomerase inhibitor
|
2018 |
Ilaria Caputo |
Application of computational approaches for designing new non-covalent immunoproteasome inhibitors
|
2018 |
Valeria Rivelli |
Identification of a new series of amides as non-covalent proteasome inhibitors
|
2018 |
Raffaello Masselli |
Discovery of 5-Lipoxygenase (5-LOX) inhibitors using Molecular Dynamics simulations, Virtual Screening and the Relaxed Complex Scheme
|
2018 |
Raffaele Palmentieri |
Nerve Growth Factor: a promising biological target for cronic pain treatment
|
2017 |
Immacolata Tramontano |
The secretase gamma modulator, current and future considerations in the development of new treatments fro Alzheimer's
|
2016 |
Michela Ruggiero |
Dynamical and Structural Insight into Partial Agonism and Antagonism of Peroxisome Proliferator-Activated Receptors γ (PPARγ)
by Adaptively Biased Molecular Dynamics.
|
2016 |
Pietro Riccio |
Molecular Studies of Stilbenzene and Phenyldiazene Derivatives with PPARγ Agonism Activities.
|
2016 |
Anna Racca |
G Protein-Coupled Receptor 119 (GPR119) for the Treatment of Diabetes
|
2016 |
Maria Morra |
Pharmacological Targeting of AMP-Activated Protein Kinase as Potential Strategy for the Treatment of Metabolic Diseases
|
2014 |
Serena Sarno |
Ligand-Based Chemoinformatics Discovery of Novel Small Molecules Inhibitors Targeting CDC25 Dual Specifity Phosphatases and Displaying in Vitro Efficancy Against Melanoma Cells.
|